Charles Schwab Trust Co Boosts Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Charles Schwab Trust Co lifted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 14.7% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 771 shares of the healthcare conglomerate’s stock after purchasing an additional 99 shares during the quarter. Charles Schwab Trust Co’s holdings in UnitedHealth Group were worth $390,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Resources Management Corp CT ADV increased its position in UnitedHealth Group by 4.2% in the second quarter. Resources Management Corp CT ADV now owns 13,839 shares of the healthcare conglomerate’s stock worth $7,048,000 after purchasing an additional 563 shares during the last quarter. Manchester Global Management UK Ltd raised its position in shares of UnitedHealth Group by 12.7% during the 2nd quarter. Manchester Global Management UK Ltd now owns 154,918 shares of the healthcare conglomerate’s stock valued at $78,894,000 after buying an additional 17,500 shares in the last quarter. Mill Creek Capital Advisors LLC grew its position in UnitedHealth Group by 20.1% in the second quarter. Mill Creek Capital Advisors LLC now owns 1,983 shares of the healthcare conglomerate’s stock worth $1,010,000 after acquiring an additional 332 shares in the last quarter. Distillate Capital Partners LLC lifted its stake in shares of UnitedHealth Group by 563,752.2% in the 2nd quarter. Distillate Capital Partners LLC now owns 129,686 shares of the healthcare conglomerate’s stock valued at $66,044,000 after purchasing an additional 129,663 shares during the last quarter. Finally, Strata Wealth Advisors LLC bought a new position in shares of UnitedHealth Group during the 2nd quarter valued at approximately $453,000. 87.86% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

UNH has been the topic of a number of analyst reports. StockNews.com cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Wednesday, January 15th. Deutsche Bank Aktiengesellschaft increased their price objective on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research report on Tuesday, December 3rd. Bank of America cut their target price on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. Piper Sandler dropped their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a report on Thursday, January 2nd. Finally, Morgan Stanley lowered their target price on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research note on Wednesday, October 16th. Two equities research analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, UnitedHealth Group has a consensus rating of “Buy” and an average target price of $627.74.

UnitedHealth Group Trading Up 2.9 %

UNH opened at $524.78 on Wednesday. The stock has a fifty day moving average price of $547.07 and a 200-day moving average price of $563.84. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a market cap of $482.95 billion, a price-to-earnings ratio of 33.86, a PEG ratio of 1.38 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $5.83 EPS. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.77 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.60%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.